特斯拉4月中國產汽車銷量按月跌14.7% 乘聯會:特斯拉漲價有利改善消費觀望心態
中國乘用車市場信息聯席會公布數據顯示,特斯拉(Tesla)(TSLA.US)4月份中國產汽車銷量75,842輛,按月下降14.7%,其中出口汽車35,886輛。
乘聯會表示,此次特斯拉漲價是很好的信號,體現車企對經營質量的關注,有利於改善消費觀望心態,讓消費者走出過度期待降價的預期,恢復正常的購買節奏。
乘聯會分析認為,乘用車行業已經脫離原來高利潤行業,3月汽車產銷雖然恢復,但汽車銷售利潤率僅4.7%,部分車企在吐血賣車,壓力太大。加上世界上最嚴的國六B標準即將實施,對車企生產帶來一定心理壓力,減產降庫存的結果帶來的是盈利較大損失。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.